FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

Recent Examples of Combination Product Approvals

• Transdermal patch for treatment of Parkinson's disease (May 2007)
  
  
• Absorbable Collagen Sponge with Genetically Engineered Human Protein (March 9, 2007)
  
  
• Device - biological product gel for surgical hemostasis (June 16, 2006)
  
  
• Iontophoretic transdermal system for fentanyl [PDF 1.05 MB]
  
  
• Transdermal patch for attention deficit hyperactive disorder (ADHD) (April 10, 2006)
  
  
• Transdermal Patch for Depression (February 28, 2006)
  
  
• Inhaled Insulin Combination Product for Diabetes (January 27, 2006)
  
  
• Dental Bone Grafting Material with Growth Factor
  
  
• Surgical Mesh with Antibiotic Coating
  
  
• Dermal Iontophoresis System
  
  
• Iontophoretic Drug Delivery Patch [PDF 137KB]and Controller [PDF 304KB]
  
  
• Methylaminolevulinate Cream with Halogen Light Source [PDF 209 KB]
  
  
• Absorbable Collagen Sponge with Genetically Engineered Human Protein
  
  
• Spinal Fusion Putty
  
  
• Paclitaxel-Eluting Coronary Stent System
  
  
• Photodynamic Therapy:
  
  Drug Approval Order [PDF 125KB]
  Drug Label [PDF 328KB]
  Device Approval Information: P020021 and P940010/S010 and P990021/S001
  
  
  
• FluMistTM Influenza Virus Vaccine, Live, Intranasal



• Tositumomab and Iodine I 131 Tositumomab



• Demagraft Human Fibroblast-Derived Dermal Substitute



• Glucose Monitor/Insulin Pump



• Antibiotic Bone Cement [PDF 217KB]



• Sirolimus-Eluting Coronary Stent
  
  FDA Press Release
  Summary Information



• Lumbar Tapered Fusion Device with Genetically Engineered Human Protein



• Peginterferon alfa-2a in Combination with Ribavirin



• Fibrin Sealant
  
  
• Dermal Collagen Implants for Aesthetic Use

PDF documents may be read with a free copy of Adobe Acrobat Reader

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility